West Pharmaceutical Services
-0.94 %
-8.34 %
Yet to be announced
Company Overview
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The company distributes its products through its sales force and distribution network.
Revenue Sources
PassBased on the company's SEC filings and business operations, West Pharmaceutical Services generates its revenue primarily from manufacturing and selling pharmaceutical packaging and delivery systems. These products and services are halal as they serve legitimate medical purposes and don't involve any prohibited substances or activities.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2025 | $804.6m | $637.2m | - | $200,000 | 0.00% | 0.03% |
| June 30, 2025 | $766.5m | $612.9m | - | $100,000 | 0.00% | 0.02% |
| March 31, 2025 | $698.0m | $591.4m | - | $400,000 | 0.00% | 0.07% |
| Dec. 31, 2024 | $748.8m | $588.4m | - | $-800,000.0 | 0.00% | 0.14% |
Analyzing the company's financial statements for the last four quarters shows that interest expenses are minimal relative to total expenses. The interest expense ratios remain consistently well below the 5% threshold that would indicate material reliance on interest-bearing debt.
Operational Ethics
PassAfter reviewing available information from company disclosures and public sources, there is no evidence of significant ongoing associations with entities involved in human rights violations. The company maintains manufacturing facilities in North America, Europe, and Asia, but there are no documented material ties to the Chinese Communist Party or the state of Israel.
Comments